After a state-funded pilot project concluded, breast cancer patients in Latvia are now forced to pay 3000 euros for crucial genetic tests themselves. These tests are vital for determining the effectiveness of chemotherapy as a treatment option.

Doctors and researchers have completed a new trial that could significantly impact women with breast cancer who have had a breast removed. The hope is that this method, which aims to improve quality of life, will become widely available.

A test that could prevent breast cancer patients from undergoing unnecessary chemotherapy is reportedly not being used enough by doctors in the Netherlands.

A groundbreaking genomic test has shown potential to free millions of breast cancer patients from the need for chemotherapy, according to results from a major international clinical trial.

A new Bellis center has opened at Poliklinika Jih in České Budějovice, offering support and resources to women in South Bohemia who are undergoing treatment for breast cancer.

Rapid-access clinics in Ireland are struggling to assess patients with suspected breast cancer within the 10-day target, with over 11,600 patients not being seen on time last year, and one hospital reportedly only able to see about one in four patients within the target.

Lithuanian breast cancer patients forced to seek medication in Latvia or Poland  LRT

Irish researchers have discovered that artificial intelligence can help determine whether breast cancer patients require chemotherapy. The study suggests that some patients may not benefit from chemotherapy, which often has debilitating side effects.

A declining number of breast cancer patients in West Denmark are receiving their treatment within the recommended timeframe. This issue highlights concerns about healthcare access and efficiency in the region.

New research from the Dutch Cancer Institute (IKNL) and Utrecht University suggests that an insufficient number of breast cancer patients are receiving a crucial gene test. This test helps determine whether chemotherapy is necessary for their treatment, potentially leading to overtreatment or undertreatment.

Results from a new international study indicate that millions of breast cancer patients worldwide could potentially avoid traditional chemotherapy. The research, led by a team at University College London (UCL) and spanning six countries, suggests a significant shift in treatment protocols.

A new study indicates that a significant number of breast cancer patients, potentially millions, could safely forgo chemotherapy treatments.

After surgery, some breast cancer patients require additional treatment to destroy remaining local tumor cells, with decisions made individually based on the type of intervention, disease stage, and tumor characteristics.

The Think Pink Bosnia and Herzegovina organization announced it will hold a European symposium in Sarajevo titled 'Quality of Life During and After Treatment: An Integrative Approach to the Care of People with Breast Cancer'.

Findings of the study, conducted by the IIT-M and Karkinos Healthcare, along with Kumaran Hospital, Chennai, and the Chennai Breast Centre, were published in the journal BMC Cancer

Doctors at Istanbul University's Oncology Institute have successfully treated four breast cancer patients without surgery, utilizing cryoablation, a minimally invasive technique.

New research on brain-targeting estrogens is emerging as a promising development in the treatment of breast cancer, building on decades of hormonal therapy as a key pillar in fighting hormone-dependent tumors.

A specialized genetic test can now reliably identify younger women with breast cancer who can survive without burdensome chemotherapy, potentially sparing more patients than previously thought.

A newly developed DNA test could allow some breast cancer patients to forgo chemotherapy. This test helps identify patients who may not benefit from the aggressive treatment.

A new genomic test developed by Veracyte can identify breast cancer patients who may safely forgo chemotherapy, offering a personalized treatment approach.

Researchers from Technion and an international team have developed and validated a new AI model that can predict the benefit of chemotherapy in breast cancer patients using routine pathology samples, offering a fast and accessible alternative to genomic tests.

The "Renaissance" association for breast cancer patients organized the "Day of Daffodils" in Sarajevo, a humanitarian event aimed at raising public awareness about breast cancer.

A Swedish report highlights that significantly more women, particularly breast cancer patients, receive rehabilitation compared to men who have had prostate cancer, raising concerns about equitable access to care.